✦ LIBER ✦

Alpha-melanocyte stimulating hormone inhibits porcine vascular smooth muscle and endothelial cell responses to tumor necrosis factor-alpha

✍ Scribed by John W. Haycock; Sheila MacNeil; Cathy M. Holt; Nadim Malik

Book ID: 119543782
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 135 KB
Volume: 39
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(02)80232-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative proteome analysis of Tumor n

Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin

✍ Hyun-Ji Cho, Jeong-Han Kang, Kwan-Kyu Park, Jung-Yoon Choe… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 724 KB

Role of cyclooxygenase-2 in tumor necros

Role of cyclooxygenase-2 in tumor necrosis factor-alpha- and angiotensin ii-mediated proliferation of vascular smooth muscle cells

✍ N.R Ferreri; W Young; A Haider; I Li; J.C McGiff 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 157 KB

Angiotensin II and tumor necrosis factor

Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia

✍ Richard Bafford; Xin Xin Sui; Grace Wang; Michael Conte 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Sildenafil inhibits the up-regulation of

Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide

✍ Shindel, A. 📂 Article 📅 2008 🏛 Elsevier Science ⚖ 54 KB

Interleukin-4 inhibits granulocyte-macro

Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro

✍ Michael C. D. Trindade; Yasuharu Nakashima; Martin Lind; Doo-Hoon Sun; Stuart B. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 779 KB

## Abstract The outcome of total joint arthroplasty is determined by biological events at the bone‐implant interface. Macrophages phagocytose implant or wear debris at the interface and release proinflammatory mediators such as interleukins 1 and 6, tumor necrosis factor‐alpha, and prostaglandin E~